Bristol-Myers Squibb
BMY
BMY
1,187 hedge funds and large institutions have $56.2B invested in Bristol-Myers Squibb in 2013 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 417 increasing their positions, 504 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.78% more ownership
Funds ownership: 68.53% → 69.3% (+0.78%)
1% more funds holding
Funds holding: 1,178 → 1,187 (+9)
17% less repeat investments, than reductions
Existing positions increased: 417 | Existing positions reduced: 504
Holders
1,187
Holding in Top 10
51
Calls
$658M
Puts
$632M
Top Buyers
| 1 | +$898M | |
| 2 | +$430M | |
| 3 | +$169M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$147M |
| 5 |
Bank of New York Mellon
New York
|
+$141M |
Top Sellers
| 1 | -$331M | |
| 2 | -$194M | |
| 3 | -$170M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$159M |
| 5 |
SAC
Smith Affiliated Capital
New York
|
-$148M |